K99 CA178205/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2014	1
2015	4
2016	4
2017	1
2018	1
2024	0

1

Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.

Cook BE, Adumeau P, Membreno R, Carnazza KE, Brand C, Reiner T, Agnew BJ, Lewis JS, Zeglis BM. Cook BE, et al. Bioconjug Chem. 2016 Aug 17;27(8):1789-95. doi: 10.1021/acs.bioconjchem.6b00235. Epub 2016 Jul 14. Bioconjug Chem. 2016. PMID: 27356886 Free PMC article.

2

A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.

Adumeau P, Carnazza KE, Brand C, Carlin SD, Reiner T, Agnew BJ, Lewis JS, Zeglis BM. Adumeau P, et al. Theranostics. 2016 Sep 28;6(12):2267-2277. doi: 10.7150/thno.16744. eCollection 2016. Theranostics. 2016. PMID: 27924162 Free PMC article.

3

Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.

Houghton JL, Zeglis BM, Abdel-Atti D, Sawada R, Scholz WW, Lewis JS. Houghton JL, et al. J Nucl Med. 2016 Mar;57(3):453-9. doi: 10.2967/jnumed.115.163824. Epub 2015 Oct 15. J Nucl Med. 2016. PMID: 26471693 Free PMC article.

4

Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.

Zeglis BM, Davis CB, Abdel-Atti D, Carlin SD, Chen A, Aggeler R, Agnew BJ, Lewis JS. Zeglis BM, et al. Bioconjug Chem. 2014 Dec 17;25(12):2123-8. doi: 10.1021/bc500499h. Epub 2014 Nov 26. Bioconjug Chem. 2014. PMID: 25418333 Free PMC article.

5

Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.

Houghton JL, Zeglis BM, Abdel-Atti D, Aggeler R, Sawada R, Agnew BJ, Scholz WW, Lewis JS. Houghton JL, et al. Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15850-5. doi: 10.1073/pnas.1506542112. Epub 2015 Dec 14. Proc Natl Acad Sci U S A. 2015. PMID: 26668398 Free PMC article.

6

Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Zeglis BM, Brand C, Abdel-Atti D, Carnazza KE, Cook BE, Carlin S, Reiner T, Lewis JS. Zeglis BM, et al. Mol Pharm. 2015 Oct 5;12(10):3575-87. doi: 10.1021/acs.molpharmaceut.5b00294. Epub 2015 Aug 31. Mol Pharm. 2015. PMID: 26287993 Free PMC article.

7

The inverse electron-demand Diels-Alder reaction as a new methodology for the synthesis of ²²⁵Ac-labelled radioimmunoconjugates.

Poty S , Membreno R , Glaser JM , Ragupathi A , Scholz WW , Zeglis BM , Lewis JS . Poty S , et al. Chem Commun (Camb). 2018 Mar 8;54(21):2599-2602. doi: 10.1039/c7cc09129j. Chem Commun (Camb). 2018. PMID: 29388990 Free PMC article.

8

Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.

Reiner T, Lewis JS, Zeglis BM. Reiner T, et al. J Vis Exp. 2015 Feb 3;(96):e52335. doi: 10.3791/52335. J Vis Exp. 2015. PMID: 25742199 Free PMC article.

9

Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.

Houghton JL, Membreno R, Abdel-Atti D, Cunanan KM, Carlin S, Scholz WW, Zanzonico PB, Lewis JS, Zeglis BM. Houghton JL, et al. Mol Cancer Ther. 2017 Jan;16(1):124-133. doi: 10.1158/1535-7163.MCT-16-0503. Epub 2016 Nov 9. Mol Cancer Ther. 2017. PMID: 28062708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year